North America Pharmaceutical Filtration Market

The North America pharmaceutical filtration market is expected to reach USD 8.54 billion by 2030 from USD 5.56 billion in 2025, registering a CAGR of 9.0% between 2025 and 2030. Market growth can be attributed to several key factors, including the increasing development and commercialization of biologics and biosimilars, as well as strict global regulatory expectations for sterility and viral safety.

The key players in the North America pharmaceutical filtration industry with a strong global footprint include Danaher Corporation (US), Solventum (US), Parker-Hannifin Corporation (US), Thermo Fisher Scientific, Inc. (US), Repligen Corporation (US), Donaldson Company, Inc. (US), and Corning Incorporated (US). Companies are adopting various growth strategies to strengthen their market positions. For instance, in June 2025, Cytiva established new filtration manufacturing lines in Pensacola, Florida, aiming to boost North America's filter membrane production capacity by 20%.

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation (US)

Danaher solidifies its position as a major force in the North America pharmaceutical filtration market through its bioprocessing brands, including Cytiva and Pall. The company delivers advanced filtration membranes, depth filters, and fully integrated single-use systems that support the production of biologics, vaccines, and cell therapies. Danaher focuses on process reliability, contamination control, and scalability, enabling manufacturers to achieve consistent, high-quality outputs. Ongoing investments in global manufacturing capacity, such as expansions across Cytiva’s filtration facilities, aim to meet the growing demand for high-throughput, end-to-end filtration solutions in next-generation biomanufacturing.

Solventum (US)

Solventum is a key participant in the pharmaceutical filtration market in North America, offering an extensive purification and filtration portfolio that spans depth and membrane filters, single-use formats, and advanced clarification solutions supporting biologics and small-molecule drugs. Its technologies are widely used in vaccines, monoclonal antibodies, gene & cell therapies, and plasma-derived products, enabling efficient, scalable, and compliant biomanufacturing for regional pharmaceutical and biopharmaceutical producers.

Parker-Hannifin (US)

Parker-Hannifin is a major player in the North America pharmaceutical filtration market, supplying advanced solutions to biopharma and pharma manufacturers. The company offers scalable, validated liquid & gas filtration systems, including clarification, sterilizing-grade, mycoplasma removal, and single-use assemblies that support vaccines, monoclonal antibodies, and other high-value biologics, while meeting stringent global GMP and regulatory requirements.

Market Ranking
The North America pharmaceutical filtration market is characterized by significant consolidation. Major companies strengthen their market positions through strategic acquisitions, advanced manufacturing capabilities, and extensive distribution networks.

Danaher (US), through its Cytiva and Pall brands, delivers integrated depth filtration, sterilizing-grade membranes, and single-use platforms that enable scalable, contamination-free bioprocessing. Solventum (US) strengthens its global filtration operations with novel depth media, bacterial retention filters, and contamination-control technologies for sterile drug production. Parker-Hannifin (US) expands its presence through high-purity filtration, gas-liquid separation systems, and process protection filters designed for reliable upstream and downstream pharmaceutical workflows.

The North America pharmaceutical filtration market is advancing rapidly with investments in high-purity membrane technologies, single-use filtration systems, automated process controls, and integrated bioprocessing platforms. Growth is driven by the rising demand for biologics, cell & gene therapies, and high-value sterile drugs, alongside stringent regulatory requirements for controlling contamination and ensuring product safety.

Related Reports:

North America Pharmaceutical Filtration Market by Product [Membrane Filter, Depth Filter, Virus Filter, Assemblies, Systems (Single-use)], Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com